Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: a year ago

Possible Interaction: Carnitine and Valproic Acid

supplement:

Carnitine

Research Papers that Mention the Interaction

An inverse correlation was found between serum concentrations of carnitine and duration of treatment in patients treated with VPA.
The mean total and free carnitine were significantly lower in both the VPA monotherapy and polytherapy groups compared with the controls.
Journal of Korean medical science  •  1997  |  View Paper
Nowhere has the popularity of carnitine been more evident than in the treatment of children taking valproic acid , which causes in some children a depression of free carnitine levels.
Pediatrics  •  1994  |  View Paper
Plasma carnitine concentrations were lower and blood ammonia values were higher in patients treated with valproic acid than in the untreated patients and control subjects.
The Journal of pediatrics  •  1982  |  View Paper
It is postulated that carnitine supplementation may increase the β-oxidation of VPA , thereby limiting cytosolic ω-oxidation and the production of toxic metabolites that are involved in liver toxicity and ammonia accumulation.
VPA inhibits the biosynthesis of carnitine by decreasing the concentration of α-ketoglutarate and may contribute to carnitine deficiency.
Clinical toxicology  •  2009  |  View Paper
The anticonvulsive drug, valproic acid (VPA), inhibits the biosynthesis of carnitine , and may contribute in this way to carnitine deficiency associated with VPA therapy.
Biochemical pharmacology  •  1996  |  View Paper
The metabolites of VPA interfere with urea cycle and cause deficiency in carnitine leading to increase in ammonia levels.
BMJ Case Reports  •  2021  |  View Paper
Carnitine levels were significantly low in patients under valproic acid therapy , however they were not found to be correlated with MDA, 8-OHdG or LFTs.
Epilepsy Research  •  2019  |  View Paper
Several studies have shown that carnitine supplementation in patients receiving VPA to result in subjective and objective improvements and to prevent VPA-induced hepatotoxicity and encephalopathy, in parallel with increases in carnitine serum concentrations.
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova  •  2017  |  View Paper
Carnitine is a commonly used antidote for acute intoxication of valproic acid , but is not a therapeutic option for management of chronic adults with adverse effects related to valproic acid.
The Journal of international medical research  •  2017  |  View Paper
Administration of not only valproic acid but also other anti-epileptic drugs was found to cause a significant decrease of free carnitine levels after adjusting the nutritional intake of carnitine.
Brain and Development  •  2015  |  View Paper
Show More